rxstat › Shortages › Cabazitaxel

Cabazitaxel (Jevtana) shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Cabazitaxel has no current shortage reported in Canada. It has been in shortage before; the history is below.

A chemotherapy medication used to treat advanced prostate cancer.

Products affected
0 / 3
Reports on file
6

Shortage history

2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Resolved
CABAZITAXEL FOR INJECTION
60MG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02487500 · ended May 19, 2025 · Delay in shipping of the drug.
Resolved
CABAZITAXEL FOR INJECTION
45MG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02487497 · ended Nov 20, 2023 · Requirements related to complying with good manufacturing practices.
Discontinued
JEVTANA
40MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02369524
Resolved
CABAZITAXEL FOR INJECTION
45MG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02487497 · ended Feb 8, 2023 · Demand increase for the drug.
Resolved
CABAZITAXEL FOR INJECTION
60MG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02487500 · ended Aug 18, 2022 · Disruption of the manufacture of the drug.
Avoided
JEVTANA
40MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02369524 · ended Jul 18, 2019

What's happening

There are no active shortage reports for Cabazitaxel. Health Canada has 6 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Cabazitaxel is classified under “PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS” (ATC L01CD).

Recent changes

Common questions

What is Cabazitaxel used for?

A chemotherapy medication used to treat advanced prostate cancer.

When will Cabazitaxel be back in stock in Canada?

Cabazitaxel has no active shortage; supply is normal per Health Canada reports.

Why is Cabazitaxel in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (plant alkaloids and other natural products)

Docetaxel (Taxotere) Widespread shortage 3 of 6 reported products affected Paclitaxel (Abraxane) Widespread shortage 3 of 7 reported products affected Topotecan (Hycamtin) Partial shortage 1 of 6 reported products affected Etoposide (Vepesid) Shortage anticipated 0 of 3 reported products affected Irinotecan No current shortage Irinotecan (Onivyde) Discontinued 0 of 1 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.